Sort
10,766 grants matching “checkpoint inhibitor”
Antigen-specific radiosensitization
$736,168Daniel Higginson · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
T cells in the aging brain
$735,570Anne Brunet · Stanford University · R01 · FY2022 · AG
Administrative Core
$735,549Jun Yan · University Of Louisville · P20 · FY2022 · GM
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$735,428Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Designer Probiotics for the treatment of intestinal infection and inflammation
$735,149Cammie Lesser · Massachusetts General Hospital · R01 · FY2019 · DK
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
$734,862Katerina Abigail Politi · Yale University · R01 · FY2019 · CA
Project 1 - Clinical Trial
$734,412Andrew R Haas · University Of Pennsylvania · P01 · FY2022 · CA
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$734,389Ticiana Leal · Emory University · UG1 · FY2022 · CA
Molecular, Cellular, and Tissue Characterization Unit
$733,794Joe W. Gray · Oregon Health & Science University · U2C · FY2020 · CA
Designer Probiotics for the treatment of intestinal infection and inflammation
$733,448Cammie Lesser · Massachusetts General Hospital · R01 · FY2020 · DK
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$733,308Mark Yarchoan · Johns Hopkins University · R01 · FY2022 · CA
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis
$732,924Annabelle Rodriguez · University Of Connecticut Sch Of Med/Dnt · R01 · FY2017 · HL
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis
$732,924Annabelle Rodriguez · University Of Connecticut Sch Of Med/Dnt · R01 · FY2018 · HL
Lympocyte Activation Gene-3 Deficiency Linked to Proinflammation and Atherosclerosis
$732,924Annabelle Rodriguez · University Of Connecticut Sch Of Med/Dnt · R01 · FY2019 · HL
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$731,268Yves Pommier · Basic Sciences · Z01 · FY2007 · CA
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease
$731,174Srikant Rangaraju · Yale University · R01 · FY2025 · AG
Building the foundations of commensal vaccines
$730,870Michael Andrew Fischbach · Stanford University · R01 · FY2025 · AI
A novel preclinical model of spontaneous metastasis
$730,435Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
ULK Inhibition Rewires Tumor and Immune Cell Metabolism
$730,407Jeffrey Paul Mackeigan · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
Understanding lung cancer genomics in patients of African ancestry
$730,400Jian Zhang · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Understanding lung cancer genomics in patients of African ancestry
$730,398Jian Zhang · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Activating Cell Death Pathways in Breast Cancer Cells
$730,319Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$729,283Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapy
$728,416Youngho Seo · University Of California, San Francisco · R01 · FY2022 · HL
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$728,153Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA